Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, United States.
Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
Neurobiol Dis. 2024 Sep;199:106602. doi: 10.1016/j.nbd.2024.106602. Epub 2024 Jul 13.
Clinical studies have reported that increased epileptiform and subclinical epileptiform activity can be detected in many patients with an Alzheimer's disease (AD) diagnosis using electroencephalogram (EEG) and this may correlate with poorer cognition. Ascorbate may have a specific role as a neuromodulator in AD as it is released concomitantly with glutamate reuptake following excitatory neurotransmission. Insufficiency may therefore result in an exacerbated excitatory/inhibitory imbalance in neuronal signaling. Using a mouse model of AD that requires dietary ascorbate (GuloAPP/PSEN1), EEG was recorded at baseline and during 4 weeks of ascorbate depletion in young (5-month-old) and aged (20-month-old) animals. Data were scored for changes in quantity of spike trains, individual spikes, sleep-wake rhythms, sleep fragmentation, and brainwave power bands during light periods each week. We found an early increase in neuronal spike discharges with age and following ascorbate depletion in AD model mice and not controls, which did not correlate with brain amyloid load. Our data also show more sleep fragmentation with age and with ascorbate depletion. Additionally, changes in brain wave activity were observed within different vigilance states in both young and aged mice, where GuloAPP/PSEN1 mice had shifts towards higher frequency bands (alpha, beta, and gamma) and ascorbate depletion resulted in shifts towards lower frequency bands (delta and theta). Microarray data supported ascorbate insufficiency altering glutamatergic transmission through the decreased expression of glutamate related genes, however no changes in protein expression of glutamate reuptake transporters were observed. These data suggest that maintaining optimal brain ascorbate levels may support normal brain electrical activity and sleep patterns, particularly in AD patient populations where disruptions are observed.
临床研究报告称,使用脑电图(EEG)可以在许多被诊断为阿尔茨海默病(AD)的患者中检测到癫痫样和亚临床癫痫样活动增加,这可能与认知能力下降有关。抗坏血酸可能作为 AD 中的一种神经调质具有特定作用,因为它在兴奋性神经递质传递后与谷氨酸再摄取同时释放。因此,不足可能导致神经元信号传递中兴奋性/抑制性失衡加剧。使用需要膳食抗坏血酸(GuloAPP/PSEN1)的 AD 小鼠模型,在年轻(5 个月大)和老年(20 个月大)动物中,在基线和 4 周抗坏血酸耗竭期间记录 EEG。每周光期内,数据的评分标准为尖峰列车数量、单个尖峰、睡眠-觉醒节律、睡眠碎片化和脑电波功率波段的变化。我们发现 AD 模型小鼠中随着年龄的增长以及抗坏血酸耗竭后神经元尖峰放电增加,而对照组则没有,这与脑淀粉样蛋白负荷无关。我们的数据还显示随着年龄的增长以及抗坏血酸耗竭后睡眠碎片化增加。此外,在年轻和老年小鼠的不同警觉状态下观察到脑电波活动的变化,其中 GuloAPP/PSEN1 小鼠向更高频率带(α、β和γ)转移,而抗坏血酸耗竭导致向更低频率带(δ和θ)转移。微阵列数据支持抗坏血酸不足通过减少谷氨酸相关基因的表达改变谷氨酸能传递,但未观察到谷氨酸摄取转运蛋白的蛋白表达变化。这些数据表明,维持最佳脑抗坏血酸水平可能支持正常的大脑电活动和睡眠模式,特别是在观察到紊乱的 AD 患者人群中。